BioWorld MedTech

Dec. 9, 2013

Boston Sci has favorable results for Precision Spectra SCS study

A study evaluating Boston Scientific's (Natick, Massachusetts) Precision Spectra Spinal Cord Stimulator (SCS), shows that the device provides highly significant pain relief three months after implantation. Read More

Life science VC funding seen falling behind overall funding growth rates

BSD begins selling MicroThermX microwave ablation in Turkey

Financings roundup: Physicians Trust prices 8.3M shares, seeks to raise more than $89 million

Grants roundup: QED program grants $600,000 to support four new technologies

Agreements/contracts: Boston Sci, Medicines Co. co-promote Premier stent

Med-tech Notes

Product briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...